Biofrontera Stock Technical Analysis
| BFRI Stock | USD 1.00 0.17 20.48% |
As of the 24th of January, Biofrontera shows the Downside Deviation of 6.35, risk adjusted performance of 0.0382, and Mean Deviation of 3.86. Biofrontera technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Biofrontera Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biofrontera, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiofronteraBiofrontera | Build AI portfolio with Biofrontera Stock |
Biofrontera Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 6.0 | Strong Buy | 2 | Odds |
Most Biofrontera analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biofrontera stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biofrontera, talking to its executives and customers, or listening to Biofrontera conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.50) | Revenue Per Share | Quarterly Revenue Growth (0.23) | Return On Assets | Return On Equity |
The market value of Biofrontera is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera's value that differs from its market value or its book value, called intrinsic value, which is Biofrontera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera's market value can be influenced by many factors that don't directly affect Biofrontera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biofrontera 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biofrontera's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biofrontera.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Biofrontera on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Biofrontera or generate 0.0% return on investment in Biofrontera over 90 days. Biofrontera is related to or competes with Gelteq Limited, ProPhase Labs, Aytu BioScience, Evogene, Dogwood Therapeutics, Sensei Biotherapeutics, and Trinity Biotech. Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treat... More
Biofrontera Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biofrontera's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biofrontera upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.35 | |||
| Information Ratio | 0.0279 | |||
| Maximum Drawdown | 32.71 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 9.59 |
Biofrontera Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biofrontera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biofrontera's standard deviation. In reality, there are many statistical measures that can use Biofrontera historical prices to predict the future Biofrontera's volatility.| Risk Adjusted Performance | 0.0382 | |||
| Jensen Alpha | 0.1244 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0282 | |||
| Treynor Ratio | 0.1375 |
Biofrontera January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0382 | |||
| Market Risk Adjusted Performance | 0.1475 | |||
| Mean Deviation | 3.86 | |||
| Semi Deviation | 4.89 | |||
| Downside Deviation | 6.35 | |||
| Coefficient Of Variation | 2493.84 | |||
| Standard Deviation | 6.41 | |||
| Variance | 41.15 | |||
| Information Ratio | 0.0279 | |||
| Jensen Alpha | 0.1244 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0282 | |||
| Treynor Ratio | 0.1375 | |||
| Maximum Drawdown | 32.71 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 9.59 | |||
| Downside Variance | 40.3 | |||
| Semi Variance | 23.92 | |||
| Expected Short fall | (5.36) | |||
| Skewness | 1.2 | |||
| Kurtosis | 7.06 |
Biofrontera Backtested Returns
Biofrontera is dangerous at the moment. Biofrontera secures Sharpe Ratio (or Efficiency) of 0.0253, which signifies that the company had a 0.0253 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Biofrontera, which you can use to evaluate the volatility of the firm. Please confirm Biofrontera's Risk Adjusted Performance of 0.0382, mean deviation of 3.86, and Downside Deviation of 6.35 to double-check if the risk estimate we provide is consistent with the expected return of 0.16%. Biofrontera has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.8, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biofrontera will likely underperform. Biofrontera right now shows a risk of 6.41%. Please confirm Biofrontera sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Biofrontera will be following its price patterns.
Auto-correlation | -0.37 |
Poor reverse predictability
Biofrontera has poor reverse predictability. Overlapping area represents the amount of predictability between Biofrontera time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biofrontera price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Biofrontera price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Biofrontera technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Biofrontera Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biofrontera volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Biofrontera Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biofrontera on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biofrontera based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biofrontera price pattern first instead of the macroeconomic environment surrounding Biofrontera. By analyzing Biofrontera's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biofrontera's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biofrontera specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 1.96 | 10.03 | 9.02 | 6.78 | Days Of Inventory On Hand | 228.24 | 130.37 | 149.93 | 229.6 |
Biofrontera January 24, 2026 Technical Indicators
Most technical analysis of Biofrontera help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biofrontera from various momentum indicators to cycle indicators. When you analyze Biofrontera charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0382 | |||
| Market Risk Adjusted Performance | 0.1475 | |||
| Mean Deviation | 3.86 | |||
| Semi Deviation | 4.89 | |||
| Downside Deviation | 6.35 | |||
| Coefficient Of Variation | 2493.84 | |||
| Standard Deviation | 6.41 | |||
| Variance | 41.15 | |||
| Information Ratio | 0.0279 | |||
| Jensen Alpha | 0.1244 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0282 | |||
| Treynor Ratio | 0.1375 | |||
| Maximum Drawdown | 32.71 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 9.59 | |||
| Downside Variance | 40.3 | |||
| Semi Variance | 23.92 | |||
| Expected Short fall | (5.36) | |||
| Skewness | 1.2 | |||
| Kurtosis | 7.06 |
Biofrontera January 24, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biofrontera stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 2.83 | ||
| Rate Of Daily Change | 1.20 | ||
| Day Median Price | 0.97 | ||
| Day Typical Price | 0.98 | ||
| Price Action Indicator | 0.12 | ||
| Market Facilitation Index | 0.06 |
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |